UK
Breakthrough £90,000 Alzheimer's drugs unlikely to benefit patients, report suggests
A major review has sparked an outcry after concluding that the drugs provide little to no discernible benefit.
A major review has sparked an outcry after concluding that the drugs provide little to no discernible benefit.
